Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001749272-21-000003
Filing Date
2021-12-17
Accepted
2021-12-17 16:01:12
Documents
1
Effectiveness Date
2021-12-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14905
  Complete submission text file 0001749272-21-000003.txt   15964
Mailing Address 35 CAMBRIDGEPARK DR. SUITE 100 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DR. SUITE 100 CAMBRIDGE MA 02140 617-863-3636
Glympse Bio, Inc. (Filer) CIK: 0001749272 (see all company filings)

EIN.: 474956987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-425703 | Film No.: 211501415